{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreielyvq5ryivan2vxqhdcbvallpjtyd2gj67hdt4gf563ajjxw22y4",
    "uri": "at://did:plc:qwnijadipydkcilpki6ufzrq/app.bsky.feed.post/3mkthuxmrm3g2"
  },
  "path": "/2026/05/01/repub/more-states-consider-dropping-glp-1-weight-loss-drugs-from-medicaid/",
  "publishedAt": "2026-05-01T15:26:59.000Z",
  "site": "https://missouriindependent.com",
  "tags": [
    "Health Care"
  ],
  "textContent": "Massachusetts and Rhode Island are considering dropping GLP-1 drugs for obesity treatment from their Medicaid programs, continuing a trend of states that have stopped coverage of these expensive medications. Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year. Medicaid programs in California, New Hampshire, […]",
  "title": "More states consider dropping GLP-1 weight loss drugs from Medicaid"
}